Our Impact


|Impact Assessment

Product Development Milestones


The product development process for new drugs, vaccines and diagnostics begins with an idea and is fully realized with the launch of an effective new product. The operational roadmap that brings each of our investments through that process is made up of a series of standard activities that are demarcated by 30+ milestones. These milestones are based on the methodology for drug development and can also be used as a reference for development of a vaccine or diagnostic.

The GHIT Fund assesses the progress of investments over time by tracking their success in meeting each milestone.


To learn more about the GHIT Fund's product development milestones, and for resources on international standards in the product development process, click here.